Journal profile · BIOLOGY
BioScience Trends
ISSN 1881-7815 · eISSN 1881-7823 · International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.) · JAPAN · Founded 2007
BioScience Trends: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 4.88; fully open access; APC about USD 140; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BioScience Trends is published by International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.) and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Liver Disease Diagnosis and Treatment, together about 28.2% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
BioScience Trends devotes to publishing the latest and most exciting advances in scientific research. Articles cover fields of life science such as biochemistry, molecular biology, clinical research, public health, medical care system, and social science in order to encourage cooperation and exchange among scientists and clinical researchers. BioScience Trends publishes Original Articles, Brief Reports, Reviews, Policy Forum articles, Communications, Editorials, News, and Letters on all aspects of the field of life science. All contributions should seek to promote international collaboration.
From the journal's Aims & Scope
Research area (LetPub): BIOLOGY
Editor-in-chief Norihiro KOKUDOPublisher website
Editorial board by country: 41 in mainland China (about 32%); most named Japan 44, Mainland China 41, United States 21, India 4, Canada 3 (128 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatocellular Carcinoma Treatment and PrognosisMedicine12.8%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine7.8%
- Liver Disease Diagnosis and TreatmentMedicine7.7%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.9%
- Pancreatic and Hepatic Oncology ResearchMedicine4.9%
- Gallbladder and Bile Duct DisordersMedicine4.8%
- COVID-19 Clinical Research StudiesMedicine4.5%
- HIV/AIDS Research and InterventionsMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePubMedCASPublisher website
Other: EBSCO, Journal Citation Reports | Clarivate Analytics, EBSCO Information Services, National Diet Library, Japan, Japan Medical Abstracts Society, JDream III, J-GLOBAL
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.88LetPub ·
- Impact factor (publisher)
- 4.9Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- SJR 2026-06
- 1.17LetPub ·
- SNIP 2026-06
- 1.31LetPub ·
- h-index
- 25LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 554OpenAlex ·
- 2-year mean citedness
- 5.39OpenAlex ·
- Self-citation rate
- 4.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 58LetPub ·
Articles by year OpenAlex count · 1,019 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 44 | 44 | 15 |
| 2025 | 61 | 61 | 271 |
| 2024 | 61 | 61 | 609 |
| 2023 | 60 | 60 | 748 |
| 2022 | 57 | 57 | 1,380 |
| 2021 | 63 | 63 | 1,835 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 140 / USD 340 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Cover letter
- Required
Article types accepted14, with length limits
- brief reportof incomplete or preliminary findings. Brief Reports should not exceed 3,000 words in length (excluding references) and should be limited to amain text ≤ 3,000 words
- brief reportsBrief Reports definitively documenting either experimental results or informative clinical observations will be considered for publication in this category.Length not stated
- communicationsCommunications are short, timely pieces that spotlight new research findings or policy issues of interest to the field of global health and medical practice tha…Length not stated
- editorialence oriented for clinical application. Editorials should not exceed 1,000 words in length (excluding references) and should be limited to amain text ≤ 1,000 words
- editorialsEditorials are short, invited opinion pieces that discuss an issue of immediate importance to the fields of global health, medical practice, and basic science o…Length not stated
- lettersLetters should present considered opinions in response to articles published in BioScience Trends in the last 6 months or issues of general interest.Length not stated
- mini reviewgures and/or tables and 100 references. Mini reviews are also accepted, which should not exceed 4,000 words in length (excluding references) and should be limit…main text ≤ 4,000 words
- mini reviewsMini reviews are also accepted, which should not exceed 4,000 words in length (excluding references) and should be limited to a maximum of 5 figures and/or tabl…Length not stated
- newsNews articles should report the latest events in health sciences and medical research from around the world.Length not stated
- original articlession, Acknowledgments, and References. Original articles should not exceed 5,000 words in length (excluding references) and should be limited to amain text ≤ 5,000 words
- original articlesOriginal Articles should be well-documented, novel, and significant to the field as a whole.Length not stated
- policy forumPolicy Forum articles discuss research and policy issues in areas related to life science such as public health, the medical care system, and social science and…Length not stated
- reviews within an area of research. Normally, reviews should not exceed 8,000 words in length (excluding references) and should be limited to amain text ≤ 8,000 words
- reviewsReviews should present a full and up-to-date account of recent developments within an area of research.Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, Peer review
- Conflicts of interest
All authors must disclose actual or potential conflicts of interest. Model summary
All authors are required to disclose any actual or potential conflict of interest including financial interests or relationships with other people or organizations that might raise questions of bias in the work repo
Source ↗Publisher website ·- Publication ethics
Follows ICMJE Recommendations for publishing and ethical standards. Model summary
BioScience Trends follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE, https://icmje.org/recommendations)
Source ↗Publisher website ·- Peer review
All original research undergoes rigorous peer review. Model summary
All original research will be subjected to a rigorous standard of peer review
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.)
- Country or region
- JAPAN
- Language
- English
- Founded
- 2007
- ISSN
- 1881-7815
- Electronic ISSN
- 1881-7823
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about BioScience Trends
What CAS zone is BioScience Trends in?
In the 2025 upgraded edition of the CAS Journal Ranking, BioScience Trends is in Zone 3 of Biology, and in Zone 3 of the minor category Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BioScience Trends?
The latest impact factor listed by LetPub is 4.88; CiteScore 8, h-index 60.
How long does peer review take at BioScience Trends?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of BioScience Trends?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of BioScience Trends based?
Of the 128 board members whose country the journal's board page names, 41 (about 32%) are in mainland China; the countries named most often are Japan (44), Mainland China (41) and United States (21). Counted from the institutions listed on the board page; for reference only.
Which databases index BioScience Trends?
According to LetPub and DOAJ records, BioScience Trends is indexed in SCIE and Scopus. The journal's website also lists Web of Science, PubMed and CAS; that list has not been checked against each database.
Is BioScience Trends open access, and what is the APC?
BioScience Trends is a fully open-access journal. APC about USD 140.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .